SciSparc Ltd. SEC filings SPRC

SciSparc Ltd. has 607 filings in SEC EDGAR's recent list, going back to Jul 18, 2014. Its latest annual report, Form 20-F, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
20-F/A Amended annual report (foreign issuer) Aug 19, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) Apr 29, 2026 Dec 31, 2025
20-F Annual report (foreign issuer) Apr 24, 2025 Dec 31, 2024
20-F/A Amended annual report (foreign issuer) May 2, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) Apr 1, 2024 Dec 31, 2023
20-F Annual report (foreign issuer) May 1, 2023 Dec 31, 2022
20-F Annual report (foreign issuer) Apr 28, 2022 Dec 31, 2021
20-F Annual report (foreign issuer) Mar 30, 2021 Dec 31, 2020
20-F Annual report (foreign issuer) Jun 15, 2020 Dec 31, 2019
20-F Annual report (foreign issuer) May 15, 2019 Dec 31, 2018
20-F Annual report (foreign issuer) Apr 30, 2018 Dec 31, 2017
20-F Annual report (foreign issuer) May 1, 2017 Dec 31, 2016

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
SPRC (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Israel
Headquarters
Tel Aviv, Israel
SEC filer status
Non-accelerated filer
SEC CIK
1611746
Former names
SciSparc Ltd./ADR (until Aug 27, 2021); Therapix Biosciences Ltd. (until Jan 28, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.